Abstract
The term neurolymphomatosis (NL) encompasses nerve infiltration by neurotropic neoplastic cells in the setting of an unknown or a known hematologic malignancy. It is a rare neurologic manifestation of non-Hodgkin lymphoma (NHL) and leukemia with a poorly defined incidence. The typical manifestations of NL are of a neuropathy that may affect peripheral nerves, nerve roots, plexus, or cranial nerves. The most common presentations include painful peripheral neuropathy or radiculopathy, cranial neuropathy, painless polyneuropathy and peripheral mononeuropathy or a mononeuropathy multiplex. Successful therapy is contingent upon the recognition of this unique neurological complication, yet the diagnosis is difficult and often elusive. Of all diagnostic tools, imaging studies are of greatest clinical utility. MRI yields abnormal findings in almost 80% of affected patients and FDG-PETappears to be a highly sensitive diagnostic method facilitating identification of NL. There is no known standard treatment for NL and therefore, optimal management is ill defined. Treatment of NL consists of either chemotherapy alone or combined with radiotherapy. An aggressive multimodality therapy can prevent neurological deterioration and is associated with a prolonged survival in a subset of patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Grisold W, Jellinger K et al (1990) Human neurolymphomatosis in a patient with chronic lymphatic leukemia. Clin Neuropathol 9(5):224–230
Kuroda Y, Nakata H et al (1989) Human neurolymphomatosis by adult T-cell leukemia. Neurology 39(1):144–146
Baehring JM, Damek D et al (2003) Neurolymphomatosis. Neuro Oncol 5(2):104–115
Grisariu S, Avni B et al (2010) Neurolymphomatosis: An international primary CNS lymphoma collaborative group report. Blood 115(24):5005–5011
Bezier M, Reguiai Z et al (2009) Neurolymphomatosis associated with Sezary syndrome. Arch Dermatol 145(3):294–296
Odabasi Z, Parrott JH et al (2001) Neurolymphomatosis associated with muscle and cerebral involvement caused by natural killer cell lymphoma: a case report and review of literature. J Peripher Nerv Syst 6(4):197–203
Julien S, Radosavljevic M et al (1999) AIDS primary central nervous system lymphoma: molecular analysis of the expressed VH genes and possible implications for lymphomagenesis. J Immunol 162(3):1551–1558
Larocca LM, Capello D et al (1998) The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood 92(3):1011–1019
McCann KJ, Ashton-Key M et al (2009) Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development. Blood 113(19):4677–4680
Montesinos-Rongen M, Kuppers R et al (1999) Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment. Am J Pathol 155(6):2077–2086
Borit A, Altrocchi PH (1971) Recurrent polyneuropathy and neurolymphomatosis. Arch Neurol 24(1):40–49
Pages M, Marty-Double C et al (2004) Sensory neuropathy as revealing symptom of neurolymphomatosis: report of a case with a 15-year duration. Eur Neurol 52(1):57–58
Tajima Y, Sudo K et al (2007) Malignant lymphoma originating in the cauda equina mimicking the inflammatory polyradiculoneuropathy. Intern Med 46(13):1029–1032
Kuntzer T, Lobrinus JA et al (2000) Clinicopathological and molecular biological studies in a patient with neurolymphomatosis. Muscle Nerve 23(10):1604–1609
Pals ST, de Gorter DJ et al (2007) Lymphoma dissemination: the other face of lymphocyte homing. Blood 110(9):3102–3111
Drillenburg P, Pals ST (2000) Cell adhesion receptors in lymphoma dissemination. Blood 95(6):1900–1910
Pals ST, Drillenburg P et al (1997) Adhesion molecules in the dissemination of non-Hodgkin’s lymphomas. Acta Haematol 97(1-2):73–80
Aho R, Ekfors T et al (1993) Pathogenesis of primary central nervous system lymphoma: invasion of malignant lymphoid cells into and within the brain parenchyma. Acta Neuropathol 86(1):71–76
Aho R, Kalimo H et al (1997) Binding of malignant lymphoid cells to the white matter of the human central nervous system: role of different CD44 isoforms, beta 1, beta 2 and beta 7 integrins, and L-selectin. J Neuropathol Exp Neurol 56(5):557–568
Albelda SM (1993) Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 68(1):4–17
Bashir R, Coakham H et al (1992) Expression of LFA-1/ICAM-1 in CNS lymphomas: possible mechanism for lymphoma homing into the brain. J Neurooncol 12(2):103–110
Kern WF, Spier CM et al (1992) Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 79(9):2432–2437
Matsumura Y, Tarin D (1992) Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340(8827):1053–1058
Osterrieder N, Kamil JP et al (2006) Marek’s disease virus: from miasma to model. Nat Rev Microbiol 4(4):283–294
Okada K, Tanaka Y et al (1997) Phenotype analysis of lymphoid cells in Marek’s disease of CD4(+) or CD8(+) T-cell-deficient chickens: occurrence of double negative T-cell tumour. Avian Pathol 26(3):525–534
Bulsara KR, Kadri PA et al (2005) Malignant lymphoma of the trigeminal region. Case illustration. J Neurooncol 73(3):279–280
Czepczynski R, Guzikowska-Ruszkowska I et al (2008) Neurolymphomatosis detected by (18)F-FDG PET/CT scan – a case report. Nucl Med Rev Cent East Eur 11(2):73–75
Dakwar E, Teja S et al (2004) Sciatic neurolymphomatosis. Neurology 63(9):1751
Iplikcioglu AC, Dinc C et al (2006) Primary lymphoma of the trigeminal nerve. Br J Neurosurg 20(2):103–105
Karadag D, Karagulle AT et al (2002) Trigeminal nerve involvement in T-cell acute lymphoblastic leukemia: value of MR imaging. Eur J Radiol 44(1):16–18
Kitzmann AS, Pulido JS et al (2008) Histologic findings in T-cell lymphoma infiltration of the optic nerve. Ophthalmology 115(5):e1–e6
Strobel K, Fischer K et al (2007) Sciatic nerve neurolymphomatosis – extent and therapy response assessment with PET/CT. Clin Nucl Med 32(8):646–648
Kinoshita M, Izumoto S et al (2003) Primary malignant lymphoma of the trigeminal region treated with rapid infusion of high-dose MTX and radiation: case report and review of the literature. Surg Neurol 60(4):343–348; discussion 348
Diaz-Arrastia R, Younger DS et al (1992) Neurolymphomatosis: a clinicopathologic syndrome re-emerges. Neurology 42(6):1136–1141
Baehring J, Cooper D (2004) Neurolymphomatosis. J Neurooncol 68(3):243–244
Dong Q, Wong KK et al (2008) Sacral nerve root neurolymphomatosis diagnosed on FDG-PET/CT and magnetic resonance imaging. Clin Nucl Med 33(1):30–31
Khong P, Pitham T et al (2008) Isolated neurolymphomatosis of the cauda equina and filum terminale: case report. Spine 33(21):E807–E811
Kim JH, Jang JH et al (2006) A case of neurolymphomatosis involving cranial nerves: MRI and fusion PET-CT findings. J Neurooncol 80(2):209–210
Levin N, Soffer D et al (2008) Primary T-cell CNS lymphoma presenting with leptomeningeal spread and neurolymphomatosis. J Neurooncol 90(1):77–83
Matano S, Shirasaki H et al (2006) Thickening of multiple cranial nerves in a patient with extranodal peripheral T-cell lymphoma. J Neuroimaging 16(2):167–169
Moore KR, Blumenthal DT et al (2001) Neurolymphomatosis of the lumbar plexus: high-resolution MR neurography findings. Neurology 57(4):740–742
Shibata-Hamaguchi A, Samuraki M et al (2007) B-cell neurolymphomatosis confined to the peripheral nervous system. J Neurol Sci 260(1–2):249–252
Boes M, Pels H et al (2008) High-grade B-cell NHL of the brachial plexus followed by infiltration of the spinal cord. J Neurol 255(1):135–137
Bokstein F, Goor O et al (2005) Assessment of neurolymphomatosis by brachial plexus biopsy and PET/CT. Report of a case. J Neurooncol 72(2):163–167
Ghobrial IM, Buadi F et al (2004) High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosis. Cancer 100(11):2403–2407
Grisold W, Klimpfinger M et al (2007) Peripheral nerve involvement in lymphoma: the meninges as the crucial barrier between meningoradicular spread and neurolymphomatosis. J Peripher Nerv Syst 12(1):58–60
Kanter P, Zeidman A et al (2005) PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis. Eur J Haematol 74(1):66–69
Koerbel A, Roser F et al (2005) Primary non-Hodgkin lymphoma of the cranial nerves mimicking neurofibromatosis Type 2. Case illustration. J Neurosurg 102(6):1166
Kosa SC, Peller PJ et al (2009) T-cell neurolymphomatosis involving cauda equina and sciatic nerves. Neurology 72(1):98
Lin M, Kilanowska J et al (2008) Neurolymphomatosis–diagnosis and assessment of treatment response by FDG PET-CT. Hematol Oncol 26(1):43–45
Ohta H (2002) A case of non-Hodgkin’s lymphoma infiltrating the brachial plexus detected by Ga-67 scintigraphy. Ann Nucl Med 16(4):297–298
Ozturk E, Arpaci F et al (2006) Detection of widespread neurolymphomatosis with 18F-FDG PET. Eur J Nucl Med Mol Imaging 33(8):975–976
Peruzzi P, Ray-Chaudhuri A et al (2009) Reversal of neurological deficit after chemotherapy in BCL-6-positive neurolymphomatosis. J Neurosurg 111(2):247–251
Pietrangeli A, Milella M et al (2000) Brachial plexus neuropathy as unusual onset of diffuse neurolymphomatosis. Neurol Sci 21(4):241–245
Rosso SM, de Bruin HG et al (2006) Diagnosis of neurolymphomatosis with FDG PET. Neurology 67(4):722–723
Seror P (2001) Brachial plexus neoplastic lesions assessed by conduction study of medial antebrachial cutaneous nerve. Muscle Nerve 24(8):1068–1070
Shima K, Ishida C et al (2008) A linear lesion along the brachial plexus on FDG-PET in neurolymphomatosis. Intern Med 47(12):1159–1160
Trojan A, Jermann M et al (2002) Fusion PET-CT imaging of neurolymphomatosis. Ann Oncol 13(5):802–805
Yazawa S, Ohi T et al (2007) Brachial plexus neurolymphomatosis: a discrepancy between electrophysiological and radiological findings. Intern Med 46(8):533–534
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Siegal, T., Grisariu, S., Avni, B., Baehring, J.M. (2012). Neurolymphomatosis. In: Batchelor, T., DeAngelis, L. (eds) Lymphoma and Leukemia of the Nervous System. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7668-0_13
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7668-0_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-7667-3
Online ISBN: 978-1-4419-7668-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)